Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.48 -0.01 (-2.48%)
As of: Nov 11, 2026 · 3:57 PM EST

Citius Pharmaceuticals (CTXR) Debt Ratio (2011 - 2026)

Updated

Citius Pharmaceuticals' (CTXR) Debt Ratio was 0.05 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 475.3% from 0.01 a year earlier.

Analysis

Citius Pharmaceuticals (CTXR) Debt Ratio (2011 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Debt Ratio at Citius Pharmaceuticals was 0.01.

  • The fiscal Q3 2026 figure ranks as the highest quarterly Debt Ratio since fiscal Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Citius Pharmaceuticals 13.45 Mn -10.82 Mn 1.00 Mn 0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.01
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
Mar 31, 2020 0.01
Dec 31, 2019 0.01
Sep 30, 2019 0.00
Jun 30, 2019 0.01
Mar 31, 2019 0.01
Dec 31, 2018 0.01
Sep 30, 2018 0.01
Jun 30, 2018 0.01
API Access

Citius Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CTXR&period=max&api_key=YOUR_API_KEY